基于灰色多指标评价模型的江苏省生物医药产业集群竞争力研究

发布时间：2018-07-07 22:57

本文选题：江苏省 + 生物医药产业　；参考：《中国药房》2015年19期

【摘要】：目的:建立适用于生物医药产业集群竞争力评价的指标体系,为评价江苏省生物医药产业集群竞争力的情况提供参考。方法:选取2012年江苏省生物医药产业集群企业为研究样本,通过问卷调查,采用灰色多指标评价方法确定权重集,构建评价样本矩阵,对创新知识溢出、创新网络组织、社会资本等3个一级指标(其中包含8个二级指标、23个三级指标)进行测评分析。结果与结论:江苏省生物医药产业集群的研发投入强度等资金相关指标偏低,存在资金短缺的问题;拥有自主知识产权的新药专利数不足,知识产权保护不力,存在自主创新动力不足的问题;产品销售率等效益性指标偏低,存在科研成果产业化不高的问题;社会文化得分在社会资本层面中不高,存在约束性的生物创新公共服务平台等软环境需要加强的问题。建议进一步加强集群企业与各科研机构之间的合作,提升企业创新动力;完善生物创新机制,提高科研成果产业化水平;积极引导各种类型的生物创新公共服务平台参与集群软环境的建设。
[Abstract]:Objective: to establish an index system for evaluating the competitiveness of biomedical industry cluster in Jiangsu province. Methods: in 2012, Jiangsu Biopharmaceutical Industry Cluster enterprises were selected as the research samples, and the weight set was determined by using the grey multi-index evaluation method, and the evaluation sample matrix was constructed to overflow the innovation knowledge and organize the innovation network. Social capital and other three first-class indicators (including 8 secondary indicators and 23 third-level indicators) were evaluated and analyzed. Results & conclusion: the R & D investment intensity of Jiangsu Biopharmaceutical Industrial Cluster is relatively low, and there is a shortage of funds, and the number of patents of new drugs with independent intellectual property rights is insufficient, and the protection of intellectual property rights is weak. There are the problems of insufficient power of independent innovation, low profit index such as product sales rate, low industrialization of scientific research achievements, low social and cultural scores in social capital, There are some problems that need to be strengthened in the soft environment such as the binding biological innovation public service platform. It is suggested that the cooperation between cluster enterprises and scientific research institutions should be further strengthened, the innovation motive force of enterprises should be enhanced, the mechanism of biological innovation should be perfected, and the level of industrialization of scientific research achievements should be improved. Actively guide various types of biological innovation public service platform to participate in the construction of cluster soft environment.
【作者单位】：中国药科大学国际医药商学院;
【基金】：江苏省软科学研究计划项目(No.BR2014065)
【分类号】：F426.72

【参考文献】